Different immunotoxins, such as VB4-845 and SS1P, both including the Pseudomonas aeruginosa exotoxin fused to anti-EpCAM or mesothelin targeting moieties, have undergone clinical trials for the treatment of HNSCC. Here, MSLN is linked to head and neck squamous cell carcinoma.